Six novel α-dicarbonyl-derived azo–hydrazones were identified as potent, bioavailable antibacterial leads with low toxicity. Their broad-spectrum inhibitory potential and drug-like profiles were confirmed via molecular docking and ADMET analyses.
No takes yet. Share an insight, caveat, or question.
Vu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: